SIG Price sensitive 21 Oct 2026, 8:32 AM

AGM Presentation to Shareholders

Sigma Healthcare Ltd

Sigma Healthcare Ltd AGM Presentation to Shareholders

Key points

  • FY26 earnings grew faster than revenue
  • $10.8bn Revenue +15.5%, $1.09bn Normalised EBIT +20.6%
  • $663m net debt, equivalent to 0.57x normalised EBITDA

Full summary

Sigma Healthcare Ltd held its Annual General Meeting on 21 October 2026, presenting strong financial results for the full year ending 30 June 2026. The company reported a revenue of $10.8 billion, a 15.5% increase from the previous year. Earnings before interest and tax (EBIT) also rose significantly, with normalized EBIT reaching $1.09 billion, a 20.6% increase. The company maintained a disciplined balance sheet with net debt of $663 million, equivalent to 0.57 times normalized EBITDA. Sigma also announced a total dividend of 4.0 cents per share, fully franked.

Outlook

Sigma plans to expand its network and grow like-for-like sales in Australia and enter selected international markets with discipline. The company also aims to differentiate its brands and capture integration and synergy benefits.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in